|Articles|May 11, 2023

Worldwide Clinical Trials Partners With Every Cure

Worldwide Clinical Trials (Worldwide) has partnered with Every Cure.

Through this new partnership, Worldwide will serve as Every Cure’s clinical trial and drug development partner. The CRO will use its clinical development and rare disease know-how to assist in identifying links between rare diseases and generic drugs on the market—all facilitated through the nonprofit’s open-source database of drug-repurposing opportunities.

Every Cure was co-founded by Dr. David Fajgenbaum, Dr. Grant Mitchell, and Tracey Sikora in 2022.

Reference

Worldwide Clinical Trials Partners with Every Cure to Accelerate Discovery of Treatments for Rare Disease Patients. (2023, May 11). Business Wire.

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Worldwide Clinical Trials Partners With Every Cure

Reference

Related Content

The Data Behind Reducing Trial Burden Without Sacrificing Quality

ACT Brief: Tavneos Trial Integrity Issues, Selective Safety Data Regulatory Pathways, and FDA PreCheck Program Launch

Why Four Regulatory Scenarios Could De-Risk Selective Safety Data Collection

NEJM Retracts Tavneos Trial Paper as FDA, EMA Both Move to Pull Amgen Drug From Market

ACT Brief: Real-Time Trial Infrastructure Gaps, Built-In Data Security, and AI-Enabled CDMO Value

Trending on Applied Clinical Trials Online

NEJM Retracts Tavneos Trial Paper as FDA, EMA Both Move to Pull Amgen Drug From Market

Real-Time Clinical Trials: What the FDA's Push Toward Continuous Oversight Means for Sponsors

ACT Brief: Real-Time Trial Infrastructure Gaps, Built-In Data Security, and AI-Enabled CDMO Value

ACT Brief: DIA Leadership and Infrastructure Priorities, Real-Time Data Review Readiness, and CLL Treatment Expansion

Built-In, Not Bolted On: Why Clinical Data Security Has to Be a Design Principle